|
|
Profile
|
Delegates :
Homitsu Senoo |
|
Incorporated :
March 3 , 2025 |
Paid in Capital :
3 Million yen |
Employees :
2 人 |
Address :
Tohoku Univ. Material Innovation Center Aoba-ku Aramaki Aza Aoba468-1, Sendai-si MIYAGI
〒980-0845
|
TEL/FAX :
/ |
URL：
https://bionto.co.jp/ |
Attachment :
|
Mission/Background :
Bionto, Inc. is a startup originating from Tohoku University, founded in March 2025. The company develops innovative healthcare and medical devices based on bio-iontronics technology, which enables conversion between electrons, ions, and molecules. With a mission to support people in living their lives authentically, Bionto aims to solve longevity challenges in aging societies through solutions applicable from clinical settings to home healthcare. |
|
Technology & Business
|
Bionto’s core technology is bio-iontronics, enabling non-invasive drug delivery and skin care via electric flow. The PMN device uses electroosmotic flow for painless transdermal drug administration. BIPP is a skin patch that generates electricity from water and delivers microcurrents for skincare. Future developments include oral care devices and hydrogel-based electrodes.
|
|
Products & Service
|
Products & Service Name
|
Stage
|
Outline
|
Milestone
|
PMN Device
|
Discovery
|
Non-invasive drug delivery using electroosmotic flow
|
Preclinical preparation & customer acquisition
|
BIPP
|
Discovery
|
Skin patch generating electricity from water for skincare
|
Technical refinement & joint
|
Oral Care Device
|
Discovery
|
Mouthpiece-type device for oral stimulation
|
Technical refinement & joint
|
Hydrogel Electrode
|
Discovery
|
Flexible cuff-type hydrogel electrode
|
Product development & customer acquisition
|
Bio-iontronics Platform
|
Discovery
|
Technology for electron-ion-molecule conversion
|
Licensing & collaborative development
|
|
Highlights
|
In our seed round, we secured 60 million yen in funding through investment from PARTNERS FUND and startup loans from the Japan Finance Corporation and the 77 Bank. We are currently accelerating customer partnerships for the commercialization and market launch of our BIPP and PMN devices, along with advancing technological development for our future product pipeline.
|
|
Hot news
|
BIPP skin patch launched and available for skincare applications. Collaborative projects with cosmetic and healthcare companies underway.
|
|
Alliance strategy
|
Seeking partners for joint development and commercialization of bio-iontronics-based devices. Open to licensing and collaborative research, especially for PMN and BIPP technologies.
|
|
|